Long-Term Effects of Statin Treatment in Elderly People: Extended Follow-Up of the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)

BACKGROUND: The PROspective Study of Pravastatin in the Elderly at Risk (PROSPER), a placebo-controlled trial of pravastatin, demonstrated a 19% reduction in coronary outcomes (p = 0.006) after a mean of 3.2 years, with no impact on stroke outcomes or all-cause mortality. However, there was a sugges...

Descripción completa

Detalles Bibliográficos
Autores principales: Lloyd, Suzanne M., Stott, David J., de Craen, Anton J. M., Kearney, Patricia M., Sattar, Naveed, Perry, Ivan, Packard, Christopher J., Briggs, Andrew, Marchbank, Laura, Comber, Harry, Jukema, J. Wouter, Westendorp, Rudi G. J., Trompet, Stella, Buckley, Brendan M., Ford, Ian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759378/
https://www.ncbi.nlm.nih.gov/pubmed/24023757
http://dx.doi.org/10.1371/journal.pone.0072642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3759378/
https://www.ncbi.nlm.nih.gov/pubmed/24023757
http://dx.doi.org/10.1371/journal.pone.0072642

Ejemplares similares